Evidence map›Paper›PMID 34858190›Full record

ReviewFrontiers in pharmacology2021

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.

Wan-Tong Zhang, Xu-Jie Wang, Chun-Miao Xue, Xin-Yu Ji, Lin Pan, Wei-Liang Weng, Qiu-Yan Li, Guo-Dong Hua, Bao-Chen Zhu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wan-Tong ZhangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xu-Jie WangXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Chun-Miao XueDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xin-Yu JiInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Lin PanDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Wei-Liang WengXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Qiu-Yan LiXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Guo-Dong HuaDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Bao-Chen ZhuDongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNXiyuan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACEI/ARBanticoagulantsidiopathic pulmonary fibrosismeta-analysisstatin

Identifiers

PMID34858190
PMCPMC8632524
OpenAlexW3214630269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.